A PCR-RFLP Method for the Detection of Activated H-ras Oncogene with a Point Mutation at Codon 12 and 61

Medicine and Dentistry

• Polymerase Chain Reaction 100%
• Restriction Fragment Length Polymorphism 66%
• Oncogene Ras 66%
• Neoplasm 50%
• Codon 50%
• Point Mutation 50%
• Bladder Tumor 50%
• Urinary System 50%
• Ras 33%
• Screening 33%
• Incidence 33%
• Mutant 33%
• Lysine 16%
• Follow up 16%
• Urine 16%
• Bladder Cancer 16%
• Glutamine 16%
• Gene Mutation 16%
• Glycine 16%
• Valine 16%
• Gene Activation 16%
• Oncogene H Ras 16%
• Polymerase 16%

Biochemistry, Genetics and Molecular Biology

• Sample 66%
• Point Mutation 50%
• Codon 50%
• Mutation 33%
• Screening 33%
• Oncogene Ras 33%
• Mutant 33%
• Incidence 33%
• Lysine 16%
• Valine 16%
• Gene Activation 16%
• Glycine 16%
• Restriction Fragment Length Polymorphism 16%
• Oncogene H Ras 16%

Neuroscience

• Restriction Fragment Length Polymorphism 66%
• Point Mutation 50%
• Oncogene Ras 33%
• Polymerase 16%
• Lysine 16%
• Gene Mutation 16%
• Gene Activation 16%
• Glutamine 16%
• Valine 16%
• Oncogene H Ras 16%